Junshi Biosciences has become the first Chinese biopharmaceutical company to float shares on both the mainland and Hong Kong stock exchanges, after the company raised nearly 4.84 billion yuan ($692 million) in an initial public offering (IPO) on Shanghai’s Nasdaq-style STAR Market on Wednesday.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
